BRISBANE, Calif. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO) – today announced an exclusive partnership aimed at ...

BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...

A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...

EDEN PRAIRIE, Minn., March 29, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to ...

Please provide your email address to receive an email when new articles are posted on . CareDx intends to develop a testing solution to use in pre-clinical animal models. CareDx will provide ...

Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver failure patients or are not eligible for or are waiting for a transplant a ...

Bioengineered organs are no longer just structural substitutes. A new review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) ...

BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO) -- today announced an exclusive ...

CareDx, Inc. CDNA and Miromatrix Medical Inc. ("Miromatrix") MIRO – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human ...